
1. oncotarget. 2017 jan 31;8(5):7248-7264. doi: 10.18632/oncotarget.14540.

carcinoma-risk variant ebna1 deregulates epstein-barr virus episomal latency.

dheekollu j(1), malecka k(1), wiedmer a(1), delecluse hj(2), chiang ak(3),
altieri dc(1), messick te(1), lieberman pm(1).

author information: 
(1)the wistar institute, philadelphia, pa usa.
(2)deutsches krebsforschungszentrum, heidelberg, germany.
(3)department pediatrics adolescent medicine, university hong kong,
hong kong.

erratum in
    oncotarget. 2019 jul 08;10(43):4505-4506.

epstein-barr virus (ebv) latent infection causative co-factor endemic
nasopharyngeal carcinoma (npc). npc-associated variants identified in
ebv-encoded nuclear antigen ebna1. here, solve x-ray crystal structure 
an npc-derived ebna1 dna binding domain (dbd) show variant amino acids
are found surface away dna binding interface. show that
npc-derived ebna1 compromised dna replication episome maintenance
functions. recombinant virus containing npc ebna1 dbd impaired their
ability immortalize primary b-lymphocytes suppress lytic transcription
during early stages b-cell infection. identify survivin host protein
deficiently bound npc variant ebna1 show survivin depletion
compromises ebv episome maintenance multiple cell types. propose that
endemic variants ebna1 play significant role ebv-driven carcinogenesis by
altering key regulatory interactions destabilize latent infection.

doi: 10.18632/oncotarget.14540 
pmcid: pmc5352318
pmid: 28077791  [indexed medline]

